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Abstract
Background . The aim of this study was to evaluate the postoperative morbidity and, in the medium-term results, the
incidence of relapses in the laparoscopic treatment of non-parasitic hepatic cysts (NPHC) and polycystic liver disease
(PCLD). Patients and methods. From 1999 to 2003, 12 patients with NPHC and 3 patients with PCLD with few large cysts
in the anterior hepatic segments underwent laparoscopic fenestration and deroofing. Results. There were no conversions
and no mortality; the mean operative time was 55 min for NPHC and 120 min for PCLD. Postoperative morbidity
comprised two patients with bronchopneumonic infiltrations and in one patient with PCLD ascites resolved spontaneously.
All the patients experienced resolution of the symptomatology. Follow-up was carried out from 3 to 38 months (mean 18
months). There was no relapse of the disease. Discussion. The preoperative selection of patients is fundamental to program
the surgical treatment. Laparoscopy can be considered a safe and efficacious treatment for NPHC and PCLD.
Key Words: Non-parasitic hepatic cyst, polycystic liver disease, laparoscopic resection, laparoscopic fenestration, laparoscopic
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Introduction
The treatment of simple hepatic cysts presents some
relevant controversies. There is no agreement about
the possibility of identifying, in the preoperative
phase, simple cysts and polycystic hepatic disease as
distinct from the cases with degeneration (cystoade-
noma, cystoadenocarcinoma). The surgical indication
and the choice of the type of surgical treatment, with
possible laparoscopic approach, on the basis of the
immediate results (postoperative morbidity) and of
the medium-term results (possibility of relapse of the
disease), are also under discussion. The classification
of hepatic cysts includes congenital and acquired
forms. We distinguish among the congenital, the
simple or sporadic forms, and polycystic disease; the
congenital forms can be associated with renal cysts.
The acquired forms include cysts as an evolution
of organized traumatic hematomas, parasitic cysts,
neoplastic cysts (cystoadenoma, cystoadenocarci-
noma), and metastatic cysts. The aim of this study
was to evaluate, in a small but homogeneous series
(from a single institution), the postoperative morbi-
dity and, in the medium-term results, the incidence
of relapses in the laparoscopic treatment of nonpara-
sitic hepatic cysts (NPHC) and of polycystic liver
disease (PCLD).
Patients and methods
Fifteen patients were examined and treated in our
institution during the period 19992003. There were
12 patients with simple hepatic cysts and only 3 with
PCLD (Figure 1); 6 males and 9 females, mean age
54 years (range 3461 years). Tables I and II show the
patients’ symptoms and Table I shows the sizes of
simple cysts (mean 12 cm, range 916 cm).
In all patients the clinical scenario was upper
abdominal quadrant pain, with irradiation to the right
shoulder in some cases. The smart type of pain,
referred to the presence of the cysts, was persistent
and severe, lasting for several months. All the patients
visited their primary care physician and underwent an
ultrasonographic evaluation before admission to the
hospital. As a result, the hepatic cysts were evident
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and in five cases the addition of cholelithiasis was
noted. On admission to our clinical institute, mor-
phologic definition of the cystic lesions was deter-
mined by CT and/or MRI examination, in order to
exclude parasitic or neoplastic origin and define the
topography of the lesions in the liver. The diagnosis
was completed by investigating tumor markers and
echinococcus serology. There was evidence of three
cases of polycystosis type 1. The indication for
surgical treatment, then, was based on the presence
of an evident symptomatology. All the patients were
submitted to a laparoscopic approach: the wide
fenestration technique (Lin procedure) [1] by deroof-
ing the cyst wall was the preferred procedure.
Cholecystectomy was added in case of lithiasis. The
laparoscopic fenestration technique was also applied
to the patients with PCLD type 1.
The treated lesions mainly involved anterior hepatic
segments (II, III, IV, and V), with the cystic walls
widely superficial on the liver, although in two
cases the cysts were located posterior-laterally, but
they were accessible by the laparoscopic approach.
The deeply localized cysts and those bordering with
the superficial ones were fenestrated a second time
and through the superficial cysts, after an explora-
tive puncture. The cutting of the cystic wall was
performed by means of electronic and ultrasonic
scalpel, and the surgeons avoided going too far
into the hepatic parenchyma. The residual cavity
was widely in communication with the peritoneum
and then drained. We registered no cases of intrao-
perative biliary leakage in the treated cysts. In situ
omentoplasty was added in the two posteriorly located
cases.
Results
There were no conversions in the intraoperative
phase for either pathology. There was no mortality.
The mean operative time for the polycystic disease
was longer (120 min) than for the simple cysts
(55 min). This difference must only be attributed to
the necessity of treating numerous cysts, and not to a
more difficult or different intervention for the poly-
cystosis. The postoperative stay, the complete resolu-
tion of the symptomatology and the histologic
results, in all the cases of biliary cysts on the
segments of the examined cystic wall, were the
same for both pathologies. There were a few minor
and nonspecific postoperative complications, such as
pleural effusions or bronchopneumonic infiltrations.
Postoperative ascites is a more important problem, as
emphasized in the literature [2]. In our series, this
complication occurred in one of the patients treated
for polycystic disease (Table III). Moreover, the
medium-term results were the most interesting. In
this series we evaluated the medium-term results
with a mean follow-up of 18 months after the
surgical intervention (range 338 months). There
Table II. Clinical findings in patients with PCLD type 1.
Patient no. Symptoms
13 Abdominal pain, dyspnea
14 Abdominal pain/gallbladder lithiasis
15 Abdominal pain
Table III. Immediate results with the laparoscopic approach.
Parameter NPHC PCLD (type 1)
Conversion No No
Mortality No No
Mean operative time
(min)
55 (range 4090) 120 (range 80150)
Bronchopneumonic
Infiltrations 1 1
Pleural effusion 1 1
Ascites No 1
Hospital stay (days) 6 (range 414) 6 (range 414)
Resolution of the
symptomatology Complete Complete
Histology of the
removed wall
Simple cyst Simple cyst
Table I. Clinical findings in patients with NPHC.
Patient
no.
Cyst/s size
(cm)
Symptoms
1 13 Epigastric pain, gallbladder lithiasis
2 10/4 Epigastric pain, gallbladder lithiasis
3 9/7 Abdominal pain
4 12 Abdominal and right shoulder pain
5 14 Abdominal pain
6 10/3 Right shoulder pain
7 9 Epigastric pain
8 16 Right shoulder pain/gallbladder
lithiasis
9 6 Epigastric pain
10 8 Abdominal pain
11 11/4 Abdominal and right shoulder pain
12 20/4 Abdominal pain/gallbladder lithiasis
Figure 1.
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was a follow-up every 6 months (except for the last
patients), and, as well as clinical observation, it
included laboratory investigations and abdominal
ultrasonographic examination. The results confirmed
the absence of both the symptomatology and the
relapse of the disease.
Discussion
Two elements of debate are in evidence: the
anatomical-clinical characteristics of the patho-
logy and the surgical indication. First of all, it is
useful to define the general clinical characteristics
of the pathology, to establish an appropriate and
adequate therapeutic program. In fact, there are
three fundamental points: this is a benign pathology,
often asymptomatic or with few signs and symptoms
(vague abdominal pain, mild dyspnea, etc.), and this
is accompanied by normal hepatic function tests.
Then, apart from the open or laparoscopic approach
(as the interventions can readily be overlapped), the
surgical indication in general must be established on
the basis of the appearance of the symptoms. These
are related to the presence of hepatic cysts, i.e. the
presence of another disease such as cholelithiasis.
The clinical scenario can be overlapping, both in
simple cysts and in polycystosis. Generally the
reported symptoms derive from the effect of the
volume of the cyst(s). Moreover, about 15% [3] of
patients are asymptomatic, but the most common
problem is the sense of heaviness and the mild pain
in the upper abdominal quadrants. Among the
complications we noticed bleeding, perforation,
torsion of pedunculated cysts: these are all unusual
in the evolution of the disease. Although rare,
infection of the cysts (more frequent in polycystosis)
and the appearance of jaundice from compression of
the biliary tree can be found [4]. The number and,
above all, the size of the cysts, such as simple cysts
and polycystosis type 1, must be considered first.
The therapeutic approach for polycystosis type 2 is
different. As mentioned above, the symptomatology
related to the cysts is vague and undefined. We
registered, in particular, epigastric or right shoulder
pain, precocious sense of gastric fullness, and
clinostatic dyspnea; in most cases there was an
indeterminate abdominal pain. There was the same
clinical scenario in polycystosis, where the painful
symptomatology and the abdominal distension,
clinostatic dyspnea, and fatigue with limitation of
physical activity because of the hepatomegaly, are
in evidence [2].
The surgical indication must be related to the
presence of the biliary cysts and not to other
concomitant pathologies (gastro-esophageal reflux,
cholelithiasis, etc.). In particular, in many cases the
hepatic cysts or the polycystosis are asymptomatic.
Subsequently, it is fundamental to define with
certainty the nature of the simple hepatic cysts, by
excluding a parasitic etiology and also the suspicion of
malignancy. This is achieved by evaluation of the
regularity of the cystic wall, densitometric character-
istics of the content, and characteristics of the
surrounding hepatic parenchyma. In addition to the
preoperative study, serology for echinococcosis and
investigation of tumor markers must be carried out.
Finally it must be determined that the surgical
indication is for cystic hepatic lesions that are
responsible for the clinical scenario and that they are
definitely nonparasitic and non-neoplastic. When the
surgical indication is established, it is necessary to
choose the type of treatment. Nonsurgical procedures
were proposed for simple cysts; percutaneous aspira-
tion, occasionally executed, has no therapeutic
role because relapses reach the 100% level [5,6].
Percutaneous aspiration, followed by the injection of
95% ethanol or other sclerosing substances, is also
followed by a high incidence of relapses [57].
Therefore, the value of this therapeutic procedure
is very debatable, especially in the light of the
disappointing results.
In this perspective, surgical treatment remains
in evidence, and its modality was codified by Lin
et al. [1] in the past. More recently the same
treatment of fenestration and deroofing was pro-
posed and largely carried out by the laparoscopic
approach and it was largely recognized as a safe
and feasible procedure. Open deroofing should be
reserved for the treatment of inaccessible cysts by
laparoscopy. On the whole, surgical therapy with
fenestration by deroofing of the cystic wall (executed
by both the open and laparoscopic approach) is
recognized as the therapy of choice for the treatment
of simple hepatic cysts because of the low morbidity
rates, the high level of effectiveness and the very
small relapse index [3,811]. Hepatic resection is
indicated as a second level choice, after a first
deroofing but with relapse of disease and/or compli-
cations [12]. In addition, hepatic resection is the
preferred treatment for patients with multiple cysts
or in PCLD and with a wide hepatic involvement
[13], but leaving a sufficient amount of hepatic
parenchyma. The hepatic resection almost invariably
requires an open approach.
The therapeutic program for the polycystic liver is
obviously more complex. Preliminarily, it is useful to
consider the classification proposed by Morino et al.
[2] that distinguishes, among the PCLD cases, a type
1 characterized by a limited number of large-sized
cysts located in the anterior hepatic segments, and a
type 2 characterized by a great number of cysts
throughout the liver. A further subdivision among
the PCLD cases was suggested by Gigot et al., which
distinguishes type 1, with large cysts (/10 cm), in
limited number (B/10); type 2 with multiple and
widespread cysts of moderate size, but with largely
undamaged parenchyma; type 3 with widespread
small cysts, but with small amounts of undamaged
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residual parenchyma [14]. In conclusion, type 1 is
almost the same as the simple hepatic cysts in the
anatomical-clinical field, and then there are the
same problems of surgical indication. For the latter,
any possible suspicion regarding malignancy must
be investigated by study of the morphology of the
internal surfaces and the parenchyma surrounding
the cysts. The programmable surgical intervention
is the same for both simple cysts and polycystosis
type 1, represented by fenestration and deroofing,
which is also perfectly feasible by the laparoscopic
approach [13]. Moreover if there is a prevalence of
the cysts in one sector, a resective procedure can
be proposed.
The therapeutic program for polycystosis type 2
(Gigot’s type 3) is much more complicated, so the
perspective of transplantation is very real. In particu-
lar, patients with congenital hepatic fibrosis and with
extensive substitution of the parenchyma by the cysts
(polycystosis type 2), are candidates for transplanta-
tion. Briefly, hepatic transplantation is generally
reserved for cases of polycystosis with severe hepatic
failure and/or in case of relapse after previous hepatic
resections. In addition, some of these patients also
suffer from polycystic kidney and kidney failure, so
combined kidney/liver transplantation can be the
appropriate treatment [1518]. The reliability and
safety of the intervention of fenestration and deroofing
of the cysts are well established now, and this
procedure can be executed with the same results by
both laparoscopic and open approaches. The fenes-
tration and deroofing procedure is not very different
in the treatment of both the hepatic polycystosis and
the simple cysts, so the relapse incidence is unim-
portant. Surgical indication requires a careful selec-
tion of the patients, recognizing the type 1 cases,
overlapping with simple cysts, for which the laparo-
scopic fenestration and deroofing are also safe and
efficacious.
In conclusion, there is a very low incidence of
relapses after the treatment of simple cysts. Simple
cysts are quite frequent in polycystosis because the
development of new cysts replaces the fenestrated and
decompressed cysts. The increase of the cyst volume
is blocked by the increase of the endo-abdominal
pressure and the surgical decompression of the
cysts can restart the development of others [2,19]. A
particular consideration must be reserved for the
possibility of the appearance of ascites in the post-
operative phase that derives from the well fenestrated
cystic cavities, and this ends with the peritoneal
absorption. In this condition the minimally invasive
approach, as in the laparotomy procedures, shows the
advantage of small-sized access points that are easily
suturable, thus avoidig leakage of ascitic liquid from
the laparotomy wound [2,13].
The laparoscopic approach, with fenestration and
deroofing, in simple hepatic cysts and in type 1
polycystosis, presents considerable advantages as
regards the immediate and medium-term results, if
we compare them to the same results obtained during
our previous experience with laparotomy. This is
largely confirmed by the literature: reduction of post-
operative pain, more comfort, early mobilization,
shorter hospital stay, considerable esthetic advantage,
but above all, the resolution of the symptomatology
and the low incidence of distant relapse of disease
[2023]. Thus, preoperative selection of patients with
simple hepatic cysts and with type 1 polycystosis is
fundamental to program the surgical treatment.
Laparoscopic fenestration and deroofing can also be
considered a safe and efficacious procedure for the
relapses, particularly for simple hepatic cysts, but
also for polycystic disease with large and superficial
cysts [2024].
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